Substantiating Efficacy Claims for Private Label Skin Care

Substantiating efficacy claims for private label skincare advertising requires a structured approach grounded in regulations, robust evidence, and careful evaluation of both raw ingredient supplier data and product-specific testing. Misleading claims risk regulatory action, consumer distrust, and brand damage. This article outlines practical steps to support claims about active ingredients, finished products, and consumer-perceived benefits, with a focus on evaluating supplier clinical data and designing simple self-assessment questionnaires for consumer testing.

Regulatory Foundations for Claim Substantiation

Cosmetic claims are regulated to ensure they are truthful and not misleading. In the European Union and UK, Regulation (EC) No 1223/2009 and the Common Criteria Regulation (EU) No 655/2013 require claims to meet six criteria: legal compliance, truthfulness, evidential support, honesty, fairness, and informed decision-making. Evidence must be adequate, verifiable, and held in the Product Information File (PIF). Claims cannot imply characteristics or functions the product does not have.

In the United States, the Federal Trade Commission (FTC) requires advertisers to possess a “reasonable basis” for objective claims before dissemination. For performance claims, this typically means “competent and reliable scientific evidence”—tests, analyses, research, or studies conducted objectively using methods generally accepted to yield accurate results.

Other markets such as Australia follow similar principles of truthfulness and evidence proportionality. The strength of evidence should match the strength of the claim. Sensory or “skin feels smoother” claims may rely on well-designed consumer perception tests, while quantitative claims such as “reduces wrinkle depth by X%” or “clinically proven hydration for 24 hours” generally require instrumental or clinical data on the finished product.

All claims—express or implied, on packaging, websites, advertising, or influencer content—must be supported. Documentation should be prepared before marketing begins and kept readily available for authorities or challenges.

Evaluating Active Ingredients and Supplier Clinical Data

Many brands begin with supplier-provided data on active ingredients. Suppliers often supply in vitro, ex vivo, or small clinical studies demonstrating benefits such as barrier repair, antioxidant activity, or collagen stimulation at specific concentrations. This information can form part of a body of evidence, but may not be sufficient on its own for finished-product claims depending on the claims being made.

Key evaluation steps include:

• Relevance of concentration and delivery. Confirm the active is present in the cream at a level comparable to the tested concentration and that the vehicle (cream base) allows adequate delivery. A study on a 5% ingredient does not automatically support a 0.5% inclusion.

• Formulation differences. Ingredients can interact with other components; a pure-ingredient study does not guarantee the same performance in a multi-ingredient cream. Bridging arguments or confirmatory testing on the finished product are often needed.

• Independence and bias. Treat supplier marketing materials with caution. Independent or peer-reviewed data carry more weight.

• 
  

Supplier data is most useful for ingredient-specific claims such as it “contains [ingredient] shown to…”) or as supporting rationale when combined with finished-product testing. Extrapolating ingredient results directly to product-level efficacy claims without additional evidence is a common regulatory risk if strong claims are made. Literature reviews alone may also be inadequate for strong efficacy claims; they serve best as background or complementary support.

A defensible approach combines: (1) ingredient literature and supplier studies for mechanistic support, (2) clinical or consumer testing of the finished product. Maintain a claims matrix that maps every advertised statement to specific data points.

Generating Product-Specific Evidence

Finished-product testing provides the strongest support. Options range from fairly simple consumer perception questionnaires to more involved instrumental measurements (corneometry for hydration, cutometry for elasticity, 3D imaging or profilometry for wrinkles) under controlled conditions to dermatologist-graded clinical studies.

For most smaller brands that use private label skin care products consumer perception or self-assessment data is the most affordable method and can stand alone for sensory and perception claims (“leaves skin soft and smooth”) to be used in conjunction with literature reviews and supplier data.

Designing Easy Self-Assessment Questionnaires for Consumer Testing

Self-assessment questionnaires are cost-effective tools for home-use tests. They capture perceived efficacy, sensory attributes, and satisfaction under realistic conditions. Well-designed questionnaires generate quantifiable data suitable for claims such as “X% of users reported improved hydration” or “skin felt smoother after 4 weeks.”

Core design principles:

• Keep questions clear, concise, and free of leading language or technical jargon.

• Use balanced response scales (5- or 7-point Likert scales from “strongly disagree” to “strongly agree,” or visual analog scales).

• Focus on attributes directly linked to intended claims (hydration, smoothness, firmness, radiance, reduced appearance of fine lines, absorption speed, non-greasy feel, etc.).

• Include timing: immediate post-application, after 1 week, after 2–4 weeks, or longer for cumulative effects.

• Collect baseline skin-state and demographics to allow subgroup analysis.

• Pre-test the questionnaire on a small group for clarity and completeness; revise ambiguous items.

• Ensure anonymity or confidentiality and obtain consent. Products should be unbranded or presented neutrally to minimize bias.

• Aim for a sufficient panel (often 30+ completers for basic claims; more for robust statistics) that matches the target consumer.

• We have a questionnaire template available to our customers that was developed for self assessment consumer testing. Contact us for details.

  
  

Sample structure for a 4-week home-use test of a private label skin care cream:

1. Screening/baseline: Age range, self-described skin type, main concerns, current routine, exclusion of recent procedures or certain actives.

2. Usage instructions reminder and compliance questions.

3. Immediate/after first use: Ease of application, absorption, residual feel, scent, initial hydration or softness perception.

4. Weekly or end-of-study assessments:

   • Compared with before using the product, my skin feels more hydrated (1–5 or 1–7 scale).

   • My skin looks smoother / more radiant / firmer.

   • The appearance of fine lines has reduced.

   • The product is non-greasy / absorbs well / is suitable for daily use.

   • Overall satisfaction and likelihood to recommend (0–10 Net Promoter-style scale).

5. Open-ended questions: What did you like most? Any improvements needed?

6. Adverse-event reporting.

   
   

Analysis should report percentages agreeing with positive statements, mean score changes from baseline where applicable, and statistical significance if powered for it. Present results accurately (“87% of participants agreed their skin felt more hydrated after 4 weeks”) rather than overstating. Combine with instrumental data when possible for stronger claims.

Questionnaires work best as part of a broader evidence package. They excel at capturing consumer-relevant benefits that instruments may miss and help refine marketing language to match real user experience.

Practical Best Practices and Common Pitfalls

Maintain a living claims substantiation file that includes protocols, raw data, statistical reports, photographs (standardized), and the claims matrix. Update it when formulas change. Match claim wording precisely to the evidence—“helps improve the appearance of…” is often safer than absolute statements. Avoid drug-borderline language unless the product is registered as such.

Common pitfalls include relying solely on supplier brochures, testing the wrong concentration or population, using small or unrepresentative panels, and failing to document the link between data and claim. Comparative claims (“better than leading brand”) require head-to-head data. “Clinically proven” implies rigorous testing that must exist on file.

Conclusion

Substantiating skincare cream claims is a proactive, evidence-based process rather than a post-hoc exercise. Start with a clear understanding of the claim’s strength and the regulatory standard it must meet. Evaluate supplier ingredient data for relevance and quality, then generate finished-product evidence through clinical, instrumental, and consumer studies. Well-designed self-assessment questionnaires provide accessible, consumer-centric data that supports perception claims. By building a coherent body of evidence and documenting it thoroughly, brands can advertise confidently, meet legal obligations, and deliver genuine value to users. Investing in robust substantiation from the development stage reduces risk and strengthens long-term credibility in a competitive market.

Disclaimer: The information in this article is for information only and does not constitute legal advice. It is general and does not take into account specific claims made by your brand. If certain claims or strong claims are made seek legal advice to ensure you comply.